Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by iQIYI, Inc. of $800 million aggregate principal amount of its 4.00%…
Davis Polk advised the representatives of the underwriters in connection with the $75 million SEC-registered follow-on offering of 9,343,750 ordinary shares of Gamida Cell Ltd, which…
Davis Polk advised the representatives of the several underwriters in connection with the $2.2 billion secondary offering of 20,125,000 shares of common stock of Fiserv, Inc. by New…
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $305.9 million secondary offering of 10,925,000 shares of common stock…
Davis Polk advised the joint book-running managers in connection with the $297.9 million secondary offering of 6,477,293 shares of common stock of Oak Street Health, Inc. by certain…
Davis Polk advised XP Inc. on its $1.23 billion equity offering of 31,654,894 Class A common shares, consisting of 7,130,435 shares sold by XP and 24,524,459 shares sold by ITB Holding…
Davis Polk advised LendingTree, Inc. in connection with the $872 million secondary offering of 2,955,984 shares of its common stock by Ventures Holdco II, LLC, which is a wholly owned…
Davis Polk advised the representatives of the underwriters in connection with the $511.5 million SEC-registered offering of 5,500,000 American Depositary Shares of BioNTech SE. In addition,…